INnate Intramedullary Threaded Nail Milestone: 5,000 Metacarpal Fractures Successfully Treated Reports ExsoMed

INnate Intramedullary Threaded Nail: To date, 5,000 metacarpal fractures have been successfully treated reports ExsoMed Corporation. This milestone reflects the rapid adoption of ExsoMed’s technology, which is quickly becoming the new standard for metacarpal fracture fixation.

INnate Intramedullary Threaded Nail: INnate is an intramedullary threaded nail designed specifically for minimally invasive fixation of metacarpal fractures. The robust length offering with innovative dual crest height design provides optimal fit within the intramedullary canal to create stable fixation and precise reduction. INnate is the only non-compression option, constructed to avoid shortening of oblique and comminuted fractures, while providing simple fracture stabilization in minutes. All instrumentation is sterile-packed and single-use, for stream-lined use in the operating room.

“The ability to treat metacarpal fractures with INnate and the intramedullary technique has been an incredible value-add to the care of my patients,” said Marc Richard, MD (Duke University Medical Center, Durham, NC). “I have been able to expand my indications for the nails and achieve excellent outcomes. It has become my ‘go-to’ technique for the majority of my operative metacarpal fractures.”

Dr. David Shenassa (Sports Medicine Associates of South Florida, Fort Lauderdale, FL) concurs, stating “INnate is one of those rare products that combines surgeon-friendly, cost effective, and game-changing for our patients. Having a sports-focused surgery center in a very active patient population, I definitely see my fair share of metacarpal fractures.  Recently, I saw a high school senior who was actively being recruited by top NCAA programs for swimming; he sustained two metacarpal fractures during critical U.S. Nationals training. INnate allowed him to get back in the pool to train just three days post-op. Both he and I were very happy with the outcome. He’s now swimming for the University of Michigan.”

“5,000 successful INnate cases is a major achievement for ExsoMed. It further validates our approach in designing and developing innovative products and technologies for hand surgery,” said James Young Kim, ExsoMed’s Managing Director of Global Sales and Marketing. “For too long, innovation has been neglected in the hand surgery space, with subpar outcomes deemed acceptable for arguably the most vital human appendages. ExsoMed is here to change that. We believe our solutions will raise the standard of care in hand surgery by providing surgeons with user-friendly surgical tools that reduce the global cost of care and get patients back to work and daily activities faster.”


Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy